Can the Board assume jurisdiction before an application is ready for allowance?
Yes, the Board of Patent Appeals and Interferences (BPAI) has the authority to assume jurisdiction over a patent application at any stage of the examination process. The MPEP 2312 explicitly states: “In an application this jurisdictional assumption may occur at any time, including before the application is otherwise in condition for allowance.” This means that…
Read MoreWhat are the examination procedures for biological material deposits in patent applications?
The examination procedures for biological material deposits in patent applications are outlined in 37 CFR 1.809. These procedures establish the process by which examiners address deposit issues during patent examination. The key points are: The USPTO initially bears the burden of establishing that access to a biological material is necessary for meeting the statutory requirements…
Read MoreHow do I assert that sequence information is identical in different formats?
When submitting sequence information in different formats (e.g., PDF, physical sheets, and computer readable form), it’s important to assert that the content is identical. The MPEP provides a sample statement for this purpose: “I hereby state that the sequence information contained in the computer readable form is identical to the sequence information contained in the…
Read MoreHow does the MPEP define “AP sites” or “abasic sites” in nucleotide sequences?
The MPEP 2412.03(d) addresses “AP sites” or “abasic sites” in the context of nucleotide sequences. According to the MPEP: “[A nucleotide can be] lacking a purine or pyrimidine nucleobase when the nucleotide is part of a nucleotide sequence, referred to as an ‘AP site’ or an ‘abasic site’.” In other words, an AP site or…
Read MoreWhat are the requirements for representing amino acid sequences in patent applications?
What are the requirements for representing amino acid sequences in patent applications? The requirements for representing amino acid sequences in patent applications are detailed in MPEP 2421.02. Key points include: Amino acid sequences must be represented using the standard three-letter or single-letter amino acid codes. Sequences with 4 or more amino acids must be included…
Read MoreHow do the sequence rules apply to amino acid sequences in patent applications?
How do the sequence rules apply to amino acid sequences in patent applications? The sequence rules in patent applications apply specifically to amino acid sequences of a certain length. According to MPEP 2412.01: “The rules require disclosure of nucleotide and/or amino acid sequences […] if a sequence is disclosed in a patent application by enumeration…
Read MoreWhy are all sequences, claimed or not, required in patent applications?
All sequences, whether claimed or only disclosed, are required in patent applications for several important reasons. According to MPEP 2421.02: “All such sequences are relevant for the purposes of building a comprehensive database and properly assessing prior art. It is therefore essential that all sequences, whether only disclosed or also claimed, be included in the…
Read MoreCan an applicant add or amend claims during an interference proceeding?
Yes, an applicant can file a motion during an interference proceeding to add or amend claims. The Manual of Patent Examining Procedure (MPEP) Section 2308.02 states: “An applicant may file a motion during the interference to add or amend a claim.” This allows applicants to adjust their claims in response to developments during the interference…
Read MoreWhat types of claim language are acceptable in patent applications?
Patent applicants have considerable flexibility in the types of claim language they can use. According to MPEP 2173.01: “Applicant may use functional language, alternative expressions, negative limitations, or any style of expression or format of claim which makes clear the boundaries of the subject matter for which protection is sought.” This means that inventors can…
Read MoreHow does 35 U.S.C. 102(a)(2) apply to patent applications?
35 U.S.C. 102(a)(2) applies to certain patent documents as prior art. The MPEP states: “U.S. patents, U.S. patent applications published under 35 U.S.C. 122(b), and international patent applications published under the Patent Cooperation Treaty to another are prior art under 35 U.S.C. 102(a)(2) if the effectively filed date of the disclosure of the reference is…
Read More